Phaxiam
FranceEntry
2018
Hold
5yr
Exit
2023
Who owns Phaxiam?
Phaxiam is a French Biotech company, formerly owned by Karista, exited in 2023 (exit via IPO). No current private equity owner is on file.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Exit Type
IPO
Buyer
Euronext Paris IPO + Erytech merger
Exit Year
2023
More from Karista HealthTech Fund
Other portfolio companies in the same fund.
Switzerland
GermanyMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Phaxiam?
Phaxiam was formerly owned by Karista, exited in 2023. No current private equity owner is on file.
Who did Phaxiam sell to?
Karista sold Phaxiam to Euronext Paris IPO + Erytech merger in 2023 (IPO).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue